Literature DB >> 8579567

Tissue expression of endothelin-1 mRNA in endotoxaemia.

S Kaddoura1, N P Curzen, T W Evans, J D Firth, P A Poole-Wilson.   

Abstract

Circulating endothelin-1 concentrations are elevated in animal models of sepsis. The major actions of endothelin-1 appear to be as a local autocrine and paracrine factor, rather than as a circulating hormone, and plasma concentrations may not reflect local tissue concentrations. We therefore measured tissue expression of mRNA encoding pre-pro-endothelin-1 by RNase protection assays, as an indicator of local production of ET-1 in an in vivo rat model of endotoxaemia. The effects of dexamethasone pre-treatment were also examined. There was a tissue-specific increase in pre-pro-endothelin-1 mRNA in endotoxaemia, apparent at 6h after endotoxin challenge in heart and lung. No significant changes in expression were seen in kidney or skeletal muscle. Dexamethasone pre-treatment significantly attenuated the rise in pre-pro-endothelin-1 mRNA in heart at 6h. Therefore, we have demonstrated tissue-specific differences in the effect of endotoxin upon pre-pro-endothelin-1 mRNA expression and in sensitivity to dexamethasone. This could account for some of the inter-tissue differences seen in local vascular response to endotoxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8579567     DOI: 10.1006/bbrc.1996.0115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Endothelial modification of pulmonary vascular tone.

Authors:  N P Curzen; K B Jourdan; J A Mitchell
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

2.  Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

3.  Endotoxemia Induces IκBβ/NF-κB-Dependent Endothelin-1 Expression in Hepatic Macrophages.

Authors:  Sarah McKenna; Megan Gossling; Alejandro Bugarini; Elizabeth Hill; Aimee L Anderson; Raymond C Rancourt; Natarajan Balasubramaniyan; Karim C El Kasmi; Clyde J Wright
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

4.  Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice.

Authors:  Ben Fogelgren; Shiming Yang; Ian C Sharp; Odaro J Huckstep; Wenbin Ma; S J Somponpun; Edward C Carlson; Catherine F T Uyehara; Scott Lozanoff
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-04

5.  Loss of the endothelial glucocorticoid receptor prevents the therapeutic protection afforded by dexamethasone after LPS.

Authors:  Julie E Goodwin; Yan Feng; Heino Velazquez; Han Zhou; William C Sessa
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

6.  C-terminal proendothelin-1 (CT-proET-1) is associated with organ failure and predicts mortality in critically ill patients.

Authors:  Lukas Buendgens; Eray Yagmur; Jan Bruensing; Ulf Herbers; Christer Baeck; Christian Trautwein; Alexander Koch; Frank Tacke
Journal:  J Intensive Care       Date:  2017-03-20

Review 7.  The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis.

Authors:  Agata Kowalczyk; Paulina Kleniewska; Michal Kolodziejczyk; Beata Skibska; Anna Goraca
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-10-07       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.